MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines

Abstract
Adjuvant use improves the quality and quantity of the immune response to pandemic influenza vaccines.

This publication has 45 references indexed in Scilit: